• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 25 Nov 2025

SBIO: Weak Q3 Financials; Still Eyeing 2026


Sabio Holdings, Inc. (SBIO:TSX) | 0 0 0.0%


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 6 pages


 

What you need to know: • Sabio reported Q3/25 financial results that missed our expectations, with revenue coming in at $8.2M (-49% YoY), compared to our estimate of $11.2M. Adjusted EBITDA was ($2.2M) vs. our expected $1.3M. • While the quarter was weak, management remains bullish on 2026, stating that its Q1 pipeline is up 60% YoY. • We urge investors to look ahead to 2026, where we are expecting 49% YoY revenue growth and 8% EBITDA margins. Yesterday, after market close, Sabio Holdings Inc. (SBIO:TSXV, SABOF:OTC) reported Q3 financial results that missed our expectations. Management attributed the weak quarter to 2025 being a non-political year and clients shifting spending to prior quarters. However, management remained highly positive on 2026, stating that it has built a strong foundation for future growth, taking advantage of the upcoming political spending. We are maintaining our BUY rating and C$1.00/share target price on Sabio Holdings. Q3/25 Highlights • Revenue came in at $8.2M (-49% YoY), missing our estimate of $11.2M. This was comprised of $6.2M in ad-supported streaming revenue (-49% YoY), $1.8M in mobile display revenue (-47% YoY), and $0.1M in other revenue (-50% YoY). Management attributed the decline to 2025 being a non-political year, where budgets shifted into early quarters ahead of the anticipated tariff impacts. Gross revenue was -11% YoY after removing political and advocacy. • Management highlighted that ad-support gross revenue was up 2% YoY when excluding political and advocacy revenue. Furthermore, programmatic scale and international expansion (+240% YoY) drove 40% of the gross revenue mix in Q3. This highlights that the business is becoming more diversified. • Sabio experienced a 54% increase in branded logos in Q3, with recurring revenue remaining at 85% over the nine-month period. 70% of its top 2024 customers increased their spend YTD, reflecting deepening client relationships. • Gross margin was 59%, below our estimate of 61% and 63% in Q3/24. • Adjusted EBITDA was ($2.2M), which missed our forecast of $1.3M. This compares to a 16% adjusted EBITDA margin in Q3/24. This reflects the shift in revenue mix and ongoing investments into growth initiatives. As a percent of revenue, S&M was 51%, G&A was 22%, and R&T was 22%. • Net income of ($3.3M) vs. our estimate of $0.7M. • Sabio ended the quarter with $2.0M in cash and $6.9M in debt, prior to completing its $1.3M equity financing on November 12th.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

SBIO: Weak Q3 Financials; Still Eyeing 2026


Sabio Holdings, Inc. (SBIO:TSX) | 0 0 0.0%


  • Published: 25 Nov 2025
  • Author: Nicholas Cortellucci, CFA
  • Pages: 6
  • Atrium Research


What you need to know: • Sabio reported Q3/25 financial results that missed our expectations, with revenue coming in at $8.2M (-49% YoY), compared to our estimate of $11.2M. Adjusted EBITDA was ($2.2M) vs. our expected $1.3M. • While the quarter was weak, management remains bullish on 2026, stating that its Q1 pipeline is up 60% YoY. • We urge investors to look ahead to 2026, where we are expecting 49% YoY revenue growth and 8% EBITDA margins. Yesterday, after market close, Sabio Holdings Inc. (SBIO:TSXV, SABOF:OTC) reported Q3 financial results that missed our expectations. Management attributed the weak quarter to 2025 being a non-political year and clients shifting spending to prior quarters. However, management remained highly positive on 2026, stating that it has built a strong foundation for future growth, taking advantage of the upcoming political spending. We are maintaining our BUY rating and C$1.00/share target price on Sabio Holdings. Q3/25 Highlights • Revenue came in at $8.2M (-49% YoY), missing our estimate of $11.2M. This was comprised of $6.2M in ad-supported streaming revenue (-49% YoY), $1.8M in mobile display revenue (-47% YoY), and $0.1M in other revenue (-50% YoY). Management attributed the decline to 2025 being a non-political year, where budgets shifted into early quarters ahead of the anticipated tariff impacts. Gross revenue was -11% YoY after removing political and advocacy. • Management highlighted that ad-support gross revenue was up 2% YoY when excluding political and advocacy revenue. Furthermore, programmatic scale and international expansion (+240% YoY) drove 40% of the gross revenue mix in Q3. This highlights that the business is becoming more diversified. • Sabio experienced a 54% increase in branded logos in Q3, with recurring revenue remaining at 85% over the nine-month period. 70% of its top 2024 customers increased their spend YTD, reflecting deepening client relationships. • Gross margin was 59%, below our estimate of 61% and 63% in Q3/24. • Adjusted EBITDA was ($2.2M), which missed our forecast of $1.3M. This compares to a 16% adjusted EBITDA margin in Q3/24. This reflects the shift in revenue mix and ongoing investments into growth initiatives. As a percent of revenue, S&M was 51%, G&A was 22%, and R&T was 22%. • Net income of ($3.3M) vs. our estimate of $0.7M. • Sabio ended the quarter with $2.0M in cash and $6.9M in debt, prior to completing its $1.3M equity financing on November 12th.

More Content

More Content

Q3/25 Recap: All Our Research in One Place!

Companies: NIM SPA CUU VAPE SCZ DRX AUAU ARG OMG BQE GEC CUU DNG EDG KRI KNR KRI MOO NIM RIO SPA SBIO LVG TM NFLD FRG NAMM SCZ CAPT GIGA MSA APM FISH

Atrium Research

SBIO: A Rising Ad-Tech Player in the Growing Streaming TV Market

Companies: Sabio Holdings, Inc.

Atrium Research

Cantech Investment Conference: Research Booklet

Companies: XX XX BQE BYL BIGG TRBE DCM YFI ENW FTG HITI MGRO GRID TTGI SBIO WELL XTRAF ANRG CLA ENW AIDX

Atrium Research

SBIO: Preliminary Q4 Financials; Best Quarter in Company History

Companies: Sabio Holdings, Inc.

Atrium Research

SBIO: Q2 Financials; Proving Consistent Revenue Growth

Companies: Sabio Holdings, Inc.

Atrium Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS - Research as a Service
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In